VYNE Therapeutics Inc.

Q2 2024 13F Holders

Symbol: VYNE
CUSIP: 92941V308
Type: Equity
Class: COM
Num filings: 33
Total reported value, excl. options: $16.0 M

Compare 2024 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type